Anti-CD20 antibodies and fusion proteins thereof and methods of use

Details for Australian Patent Application No. 2009202613 (hide)

Owner Immunomedics, Inc.

Inventors Goldenberg, David M.; Qu, Zhengxing; Hansen, Hans

Agent Davies Collison Cave

Pub. Number AU-B-2009202613

Parent 2003208415

Filing date 29 June 2009

Wipo publication date 16 July 2009

Acceptance publication date 18 August 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

16 July 2009 Application Open to Public Inspection

  Published as AU-B-2009202613

16 July 2009 Complete Application Filed

18 August 2011 Application Accepted

  Published as AU-B-2009202613

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202614-Automatic detection of program subject matter and scheduling padding

2009202612-Providing reports associated with selling of a product by one or more entities